Glycanova As
GlycaNova AS is a privately held Norwegian biotechnology company that develops and commercializes proprietary beta-glucan immune-modulating products from medicinal mushroom mycelia, selling dietary supplements, skin creams, food-grade bulk ingredients, and animal feed additives.
- Company typePrivate
- Founded2005
- HeadquartersFredrikstad, Norway
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Glycanova As does
GlycaNova AS is a privately held Norwegian biotechnology company headquartered at Fredrikstad Innovation Park, Gamle Fredrikstad, Norway. The company focuses on immune system modulation using proprietary 1,3 beta-glucans derived from medicinal mushroom (Lentinula edodes) mycelia and commercializes four brands: Lentinex (an immune-enhancing dietary supplement), Ganodex (a topical moisturising cream marketed for psoriasis and eczema), Immuna (a bulk powder nutraceutical ingredient for food and beverage fortification), and LentiGuard (an animal and fish feed additive). The central technical asset is a proprietary fermentation-based manufacturing process that isolates undenatured beta-glucan while preserving its triple helix three-dimensional structure, with the company claiming superior bioavailability and bioactivity relative to denatured beta-glucan from competing suppliers.
Glycanova As firmographics
Firmographics- Name
- Glycanova As
- Legal name
- GlycaNova AS
- Website
- https://glycanova.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- GlycaNova AS is a privately held Norwegian biotechnology company that develops and commercializes proprietary beta-glucan immune-modulating products from medicinal mushroom mycelia, selling dietary supplements, skin creams, food-grade bulk ingredients, and animal feed additives.
- Ownership category
- akta.pro rank
Glycanova As industry classification
Industry- Product category
- Biotechnology ingredients and immune-health supplements
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Microbial Fermentation Gums (Xanthan, Gellan, Pullulan, Dextran) (AFAJAMAC)
- akta.pro secondary industries
- Xanthan & Gellan (Microbial Fermentation Gums) (AFAJABAF), Hydrocolloids, Thickeners & Gelling Agents (Pectin, Xanthan, Carrageenan, Gelatin) (CRADAOAD), Hydrocolloid Stabilizers (Xanthan, Guar, Locust Bean, Carrageenan, Alginate, Pectin, Cellulose) (AFAJACAF)
Keywords
Where Glycanova As is headquartered
LocationHeadquarters
- HQ city
- Fredrikstad
- HQ country
- Norway
- HQ region
- Europe
Offices1 record
Markets served
Glycanova As business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Lentinex (Dietary Supplement): Immune enhancing dietary supplement sold to consumers. GRAS approved and Novel Food approved product sold through direct e-commerce and distribution partners.
- Ganodex (Topical Cream): Immune modifying cream for problem skin conditions (psoriasis, eczema). Sold directly to consumers via e-commerce at ganodex.com.
- Immuna (Bulk Nutraceutical Ingredient): Highest quality solid beta-glucan nutraceutical product sold in bulk (dry powder) as an immune stimulating/modifying ingredient to food and beverage manufacturers. GRAS approved in US and Novel Food approved in EU.
- LentiGuard (Animal Feed Additive): Animal and fish feed product containing bio-active beta glucan. Available for purchase as an active ingredient for pet food and aquatic feed products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Ganodex moisturising cream - single retail product |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels1 record
Glycanova As product offering
Product offeringCore offering
GlycaNova AS manufactures and sells fermentation-derived, unmodified beta-glucan products under the Lentinex®, Ganodex™, Immuna®, and LentiGuard brands. Offerings span consumer immune-support supplements, a topical skin-condition product (Ganodex™), bulk ingredient powder (Immuna®) for food and beverage manufacturers, and an aquaculture-feed additive (LentiGuard), all produced from Lentinula edodes (shiitake) mycelia via a proprietary patented process.
Product overview
Glycanova As is a Norwegian biotechnology company offering four commercially available products based on proprietary beta-glucan technology derived from medicinal mushrooms. The portfolio includes Lentinex® (immune enhancing dietary supplement), Ganodex™ (skin cream for psoriasis/eczema), Immuna® (bulk powder nutraceutical ingredient for food/beverage fortification), and LentiGuard (animal feed additive). All products leverage the company's proprietary fermentation process that preserves the triple helix three-dimensional structure of beta-glucans for enhanced bioavailability and biological activity.
Differentiator
Problem solved
Functional benefit
Brands
- Lentinex®: Immune enhancing dietary supplement containing beta-glucan from Lentinula edodes mycelium, exported via proprietary fermentation process that preserves the natural three-dimensional helical shape for high efficacy.
- Ganodex™
- Immuna®
- LentiGuard
Products and services
- Lentinex® Oral beta-glucan dietary supplement for immune support, made from fermentation-derived unmodified Lentinula edodes beta-glucan and sold to health-conscious individual consumers.
- Ganodex™ Topical beta-glucan product positioned for skin condition/skin health application, marketed to individual consumers.
- Immuna® Bulk fermentation-derived unmodified beta-glucan ingredient powder supplied to food, beverage, and dietary supplement manufacturers for use as a functional ingredient.
- LentiGuard Beta-glucan-based feed additive supplied to aquaculture and animal-nutrition producers to support animal immune health and performance.
Quantifiable outcome
- Doubling of B-cells demonstrated in murine immune system studies
- +2 more outcomes
Companies that use Glycanova As
Customer profileSegments3 records
Ideal customer profiles3 records
Glycanova As technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Glycanova As partnerships and signals
Strategic signalScale indicators1 record
Recent moves5 records
Expansion highlights4 records
Glycanova As competitors and assessment
Company assessmentDirect peers
- Lesaffre: Lesaffre markets yeast beta-glucan and other fermentation-derived immune ingredients to F&B manufacturers, positioning it as a direct competitor to GlycaNova's bulk Immuna ingredient business.
- Kemin Industries: Kemin produces immune-support and beta-glucan ingredients for human and animal nutrition, making it a comparable specialty-ingredient peer to GlycaNova across its human supplement, food ingredient, and feed additive product lines.
- Biorigin: Biorigin produces yeast-derived beta-glucan and other fermentation ingredients for animal nutrition, mirroring GlycaNova's LentiGuard positioning in immune-supportive feed additives.
- Kerry Group: Kerry owns the Wellmune brand of yeast-derived beta-glucan, the dominant immune-health B2B ingredient directly competing with GlycaNova's Immuna across food, beverage, and supplement applications.
- Real Mushrooms: Real Mushrooms is a consumer-facing mushroom extract supplement brand focused on immune support, making it a direct D2C and retail-channel competitor to GlycaNova's Lentinex supplement.
- Lallemand: Lallemand supplies yeast-derived beta-glucan ingredients for human nutrition and animal/aquaculture feed, directly comparable to both GlycaNova's Immuna (B2B ingredient) and LentiGuard (animal health) offerings.
- Host Defense (Fungi Perfecti): Host Defense markets shiitake-derived and other mushroom-based immune supplements under the Paul Stamets brand, directly competing with GlycaNova's Lentinex dietary supplement in the medicinal-mushroom consumer segment.
Broad incumbents
- Ohly (ABF Ingredients): Ohly supplies yeast-based flavor and nutritional ingredients (including beta-glucan) to the food, beverage, and supplement industries, making it a comparable but broader fermentation-ingredient incumbent.
- dsm-firmenich: DSM-firmenich is a global life sciences and nutrition ingredients major with an immune-health portfolio that overlaps with GlycaNova's beta-glucan and fermentation-derived nutraceutical ingredients, though across a much broader range of actives and categories.
- Phibro Animal Health: Phibro is a diversified animal health and nutrition company whose specialty feed additives portfolio (including immune-support ingredients) competes with GlycaNova's LentiGuard offering in the aquaculture and livestock feed segment.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Glycanova As social profiles
Digital presenceGlycanova As compliance and trust
Trust signalCompliance3 records
Glycanova As financial estimates
Financial estimateRevenue estimate
Valuation estimate
Glycanova As leadership team
Management profileNumber of profiles
Profiles4 records
Glycanova As funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Glycanova As M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Glycanova As
What does Glycanova As do?
GlycaNova AS manufactures and sells fermentation-derived, unmodified beta-glucan products under the Lentinex®, Ganodex™, Immuna®, and LentiGuard brands. Offerings span consumer immune-support supplements, a topical skin-condition product (Ganodex™), bulk ingredient powder (Immuna®) for food and beverage manufacturers, and an aquaculture-feed additive (LentiGuard), all produced from Lentinula edodes (shiitake) mycelia via a proprietary patented process.
Is Glycanova As a public or private company?
Glycanova As is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Glycanova As founded?
Glycanova As was founded in 2005. It employs 11 to 50 people.
Where is Glycanova As based?
Glycanova As is headquartered in Fredrikstad, Norway, in the Europe region.
How does Glycanova As make money?
Four revenue lines are on record. Lentinex (Dietary Supplement) is the primary driver. The others are ganodex (Topical Cream), immuna (Bulk Nutraceutical Ingredient) and lentiGuard (Animal Feed Additive).
Who are Glycanova As's main competitors?
Direct peers on record are Lesaffre, Kemin Industries, Biorigin, Kerry Group, Real Mushrooms, Lallemand and Host Defense (Fungi Perfecti). Broad incumbents are Ohly (ABF Ingredients), dsm-firmenich and Phibro Animal Health.
Does Glycanova As have an API?
No public API is recorded for Glycanova As.
What industry is Glycanova As in?
Glycanova As's product category is Biotechnology ingredients and immune-health supplements. Its primary akta.pro industry code is AFAJAMAC, Microbial Fermentation Gums (Xanthan, Gellan, Pullulan, Dextran), with a secondary code of AFAJABAF, Xanthan & Gellan (Microbial Fermentation Gums). Its NAICS code is 325411 and its SIC code is 2833.